327 related articles for article (PubMed ID: 21611195)
1. GATA3 expression is decreased in psoriasis and during epidermal regeneration; induction by narrow-band UVB and IL-4.
Rácz E; Kurek D; Kant M; Baerveldt EM; Florencia E; Mourits S; de Ridder D; Laman JD; van der Fits L; Prens EP
PLoS One; 2011; 6(5):e19806. PubMed ID: 21611195
[TBL] [Abstract][Full Text] [Related]
2. IL-4 Downregulates IL-1β and IL-6 and Induces GATA3 in Psoriatic Epidermal Cells: Route of Action of a Th2 Cytokine.
Onderdijk AJ; Baerveldt EM; Kurek D; Kant M; Florencia EF; Debets R; Prens EP
J Immunol; 2015 Aug; 195(4):1744-52. PubMed ID: 26170379
[TBL] [Abstract][Full Text] [Related]
3. DZ2002 alleviates psoriasis-like skin lesions via differentially regulating methylation of GATA3 and LCN2 promoters.
Chen L; Lin Z; Liu Y; Cao S; Huang Y; Yang X; Zhu F; Tang W; He S; Zuo J
Int Immunopharmacol; 2021 Feb; 91():107334. PubMed ID: 33412493
[TBL] [Abstract][Full Text] [Related]
4. CD8(+) T cells mediate RAS-induced psoriasis-like skin inflammation through IFN-γ.
Gunderson AJ; Mohammed J; Horvath FJ; Podolsky MA; Anderson CR; Glick AB
J Invest Dermatol; 2013 Apr; 133(4):955-63. PubMed ID: 23151849
[TBL] [Abstract][Full Text] [Related]
5. Luteolin-7-glucoside inhibits IL-22/STAT3 pathway, reducing proliferation, acanthosis, and inflammation in keratinocytes and in mouse psoriatic model.
Palombo R; Savini I; Avigliano L; Madonna S; Cavani A; Albanesi C; Mauriello A; Melino G; Terrinoni A
Cell Death Dis; 2016 Aug; 7(8):e2344. PubMed ID: 27537526
[TBL] [Abstract][Full Text] [Related]
6. PI3Kδ Sustains Keratinocyte Hyperproliferation and Epithelial Inflammation: Implications for a Topically Druggable Target in Psoriasis.
Mercurio L; Morelli M; Scarponi C; Scaglione GL; Pallotta S; Albanesi C; Madonna S
Cells; 2021 Oct; 10(10):. PubMed ID: 34685616
[TBL] [Abstract][Full Text] [Related]
7. Asymmetric stem-cell division ensures sustained keratinocyte hyperproliferation in psoriatic skin lesions.
Jia HY; Shi Y; Luo LF; Jiang G; Zhou Q; Xu SZ; Lei TC
Int J Mol Med; 2016 Feb; 37(2):359-68. PubMed ID: 26707630
[TBL] [Abstract][Full Text] [Related]
8. Loss of epidermal Evi/Wls results in a phenotype resembling psoriasiform dermatitis.
Augustin I; Gross J; Baumann D; Korn C; Kerr G; Grigoryan T; Mauch C; Birchmeier W; Boutros M
J Exp Med; 2013 Aug; 210(9):1761-77. PubMed ID: 23918954
[TBL] [Abstract][Full Text] [Related]
9. Obesity exacerbates imiquimod-induced psoriasis-like epidermal hyperplasia and interleukin-17 and interleukin-22 production in mice.
Kanemaru K; Matsuyuki A; Nakamura Y; Fukami K
Exp Dermatol; 2015 Jun; 24(6):436-42. PubMed ID: 25777289
[TBL] [Abstract][Full Text] [Related]
10. Epidermal CD147 expression plays a key role in IL-22-induced psoriatic dermatitis.
Peng C; Zhang S; Lei L; Zhang X; Jia X; Luo Z; Huang X; Kuang Y; Zeng W; Su J; Chen X
Sci Rep; 2017 Mar; 7():44172. PubMed ID: 28272440
[TBL] [Abstract][Full Text] [Related]
11. Capsaicin attenuates imiquimod-induced epidermal hyperplasia and cutaneous inflammation in a murine model of psoriasis.
Chan TC; Lee MS; Huang WC; Chang WY; Krueger JG; Tsai TF
Biomed Pharmacother; 2021 Sep; 141():111950. PubMed ID: 34328106
[TBL] [Abstract][Full Text] [Related]
12. Oxidation reduction is a key process for successful treatment of psoriasis by narrow-band UVB phototherapy.
Gu X; Nylander E; Coates PJ; Nylander K
Acta Derm Venereol; 2015 Feb; 95(2):140-6. PubMed ID: 24909845
[TBL] [Abstract][Full Text] [Related]
13. Effective treatment of psoriasis with narrow-band UVB phototherapy is linked to suppression of the IFN and Th17 pathways.
Rácz E; Prens EP; Kurek D; Kant M; de Ridder D; Mourits S; Baerveldt EM; Ozgur Z; van IJcken WF; Laman JD; Staal FJ; van der Fits L
J Invest Dermatol; 2011 Jul; 131(7):1547-58. PubMed ID: 21412260
[TBL] [Abstract][Full Text] [Related]
14. Biological Effects of IL-26 on T Cell-Mediated Skin Inflammation, Including Psoriasis.
Itoh T; Hatano R; Komiya E; Otsuka H; Narita Y; Aune TM; Dang NH; Matsuoka S; Naito H; Tominaga M; Takamori K; Morimoto C; Ohnuma K
J Invest Dermatol; 2019 Apr; 139(4):878-889. PubMed ID: 30423328
[TBL] [Abstract][Full Text] [Related]
15. GATA3 regulates FLG and FLG2 expression in human primary keratinocytes.
Zeitvogel J; Jokmin N; Rieker S; Klug I; Brandenberger C; Werfel T
Sci Rep; 2017 Sep; 7(1):11847. PubMed ID: 28928464
[TBL] [Abstract][Full Text] [Related]
16. PARP2 promotes inflammation in psoriasis by modulating estradiol biosynthesis in keratinocytes.
Antal D; Pór Á; Kovács I; Dull K; Póliska S; Ujlaki G; Demény MÁ; Szöllősi AG; Kiss B; Szegedi A; Bai P; Szántó M
J Mol Med (Berl); 2023 Aug; 101(8):987-999. PubMed ID: 37351597
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-29 induces epithelial production of CXCR3A ligands and T-cell infiltration.
Witte E; Kokolakis G; Witte K; Warszawska K; Friedrich M; Christou D; Kirsch S; Sterry W; Volk HD; Sabat R; Wolk K
J Mol Med (Berl); 2016 Apr; 94(4):391-400. PubMed ID: 26612594
[TBL] [Abstract][Full Text] [Related]
18. Epidermal barrier and oxidative stress parameters improve during in 311 nm narrow band UVB phototherapy of plaque type psoriasis.
Darlenski R; Hristakieva E; Aydin U; Gancheva D; Gancheva T; Zheleva A; Gadjeva V; Fluhr JW
J Dermatol Sci; 2018 Jul; 91(1):28-34. PubMed ID: 29610017
[TBL] [Abstract][Full Text] [Related]
19. Ustekinumab improves psoriasis-related gene expression in noninvolved psoriatic skin without inhibition of the antimicrobial response.
Baerveldt EM; Onderdijk AJ; Kurek D; Kant M; Florencia EF; Ijpma AS; van der Spek PJ; Bastiaans J; Jansen PA; van Kilsdonk JW; Laman JD; Prens EP
Br J Dermatol; 2013 May; 168(5):990-8. PubMed ID: 23278632
[TBL] [Abstract][Full Text] [Related]
20. Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation.
Johnston A; Fritz Y; Dawes SM; Diaconu D; Al-Attar PM; Guzman AM; Chen CS; Fu W; Gudjonsson JE; McCormick TS; Ward NL
J Immunol; 2013 Mar; 190(5):2252-62. PubMed ID: 23359500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]